![Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study | SpringerLink Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00417-007-0561-1/MediaObjects/417_2007_561_Fig2_HTML.jpg)
Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study | SpringerLink
![Figure 2 from Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label Figure 2 from Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label](https://d3i71xaburhd42.cloudfront.net/d90403c7be391bf40f69f01890d420865908769d/5-Figure2-1.png)
Figure 2 from Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label
![John Libbey Eurotext - European Journal of Dermatology - Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study John Libbey Eurotext - European Journal of Dermatology - Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study](http://www.jle.com/e-docs/00/04/10/A7/texte_alt_jleejd00120_gr3.jpg)
John Libbey Eurotext - European Journal of Dermatology - Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study
![Topical 5-fluorouracil and Imiquimod Efficacy in Basal and Squamous Cell Carcinomas - Skin Cancer and Reconstructive Surgery Center Topical 5-fluorouracil and Imiquimod Efficacy in Basal and Squamous Cell Carcinomas - Skin Cancer and Reconstructive Surgery Center](https://scarscenter.com/wp-content/uploads/2017/12/SCARS-Center-topical-5-fluorouracil-efficacy-in-basal-cell-carcinoma-skin-cancer1.jpg)
Topical 5-fluorouracil and Imiquimod Efficacy in Basal and Squamous Cell Carcinomas - Skin Cancer and Reconstructive Surgery Center
![Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial - The Lancet Oncology Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2021742740/2041575949/gr1.gif)
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial - The Lancet Oncology
![Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12886-015-0024-0/MediaObjects/12886_2015_24_Fig2_HTML.gif)
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text
![The Combination of Fractionated Erbium:YAG Laser Skin Microporation and Topical Imiquimod Is A New, Safe And Efficient Strategy for the Treatment of Actinic Keratosis and Basal Cell Carcinoma: Report of Two Pilot The Combination of Fractionated Erbium:YAG Laser Skin Microporation and Topical Imiquimod Is A New, Safe And Efficient Strategy for the Treatment of Actinic Keratosis and Basal Cell Carcinoma: Report of Two Pilot](https://openaccesspub.org/article/145/images/image5.jpg)
The Combination of Fractionated Erbium:YAG Laser Skin Microporation and Topical Imiquimod Is A New, Safe And Efficient Strategy for the Treatment of Actinic Keratosis and Basal Cell Carcinoma: Report of Two Pilot
![How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/imiquimod-aks-mild.jpg)
How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand
![Hypertrophic and Keloid Scars After the Application of 5% Imiquimod Cream: A Report of 2 Cases | Actas Dermo-Sifiliográficas Hypertrophic and Keloid Scars After the Application of 5% Imiquimod Cream: A Report of 2 Cases | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1578219014002078:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Arwv3Y311P1BwvDhOB51h0HUZIO+IsLePK4OCKM0IqBYLtDzD1DXDvnOEZ93gZ4Yt6pBGmuR7csqCfYfAfDPn4u7o1gK4a/DP4svAc5C2SOn6LdAC71odQyAt/Ln8oxpUGmTu4NrwYMt+C/0tiKH7hNun5ujJ/RJkngMa+qvlRURxiFwXFPwS/8PHBLe/Y+gbDqlO0rZiMfWfsDy04RkY4g=)
Hypertrophic and Keloid Scars After the Application of 5% Imiquimod Cream: A Report of 2 Cases | Actas Dermo-Sifiliográficas
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CT095020020-e_Fig1.jpg.jpg)
Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology
![Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream – JCAD | The Journal of Clinical and Aesthetic Dermatology Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/zeichnerfig3.jpg)
Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. | Semantic Scholar Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6dffa3c50c04064290051e83dbf4e0acaabde423/1-Figure1-1.png)
Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. | Semantic Scholar
![Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response | SpringerLink Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-015-0088-z/MediaObjects/13555_2015_88_Fig7_HTML.jpg)
Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response | SpringerLink
![Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream – JCAD | The Journal of Clinical and Aesthetic Dermatology Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/zeichnerfig5.jpg)